Neuronetics (STIM) Equity Average (2018 - 2026)

Neuronetics (STIM) has 9 years of Equity Average data on file, last reported at $19.8 million in Q1 2026.

• Equity Average for Q1 2026 came in at $19.8 million, down 44.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.8 million (down 44.62% YoY), and the FY2025 annual result was $29.0 million, down 12.05% from the prior year.
• Equity Average fell to $19.8 million in Q1 2026 per STIM's latest filing, from $26.8 million in the prior quarter.
• Over five years, Equity Average peaked at $80.9 million in Q1 2022 and troughed at $14.4 million in Q3 2024.
• A 5-year average of $40.8 million and a median of $35.7 million in 2025 frame the typical range for Equity Average.
• The sharpest annual moves came in 2024 and 2025: Equity Average sank 65.51% in 2024, then jumped 104.62% in 2025.
• A 5-year view of Equity Average shows it stood at $60.0 million in 2022, then tumbled by 39.92% to $36.1 million in 2023, then plunged by 42.91% to $20.6 million in 2024, then jumped by 30.15% to $26.8 million in 2025, then retreated by 26.29% to $19.8 million in 2026.
• Business Quant data shows STIM's Equity Average at $19.8 million in Q1 2026, $26.8 million in Q4 2025, and $29.4 million in Q3 2025.